Sclerosing encapsulating peritonitis: a case series from a single U.K. center during a 10-year period.
Sclerosing encapsulating peritonitis (SEP) is a serious complication of peritoneal dialysis (PD). Previous reports place the prevalence of SEP at 0.54%-7.3%. We estimated the prevalence of SEP in our unit to be 1.4% over the period 1989-1999. We here present the 6 identified cases. All of the patients presented with small-bowel obstruction; hemorrhagic ascites was identified in 3 cases. All 6 patients experienced ultrafiltration inadequacy, and 5 were treated with glucose polymer (icodextrin; duration of treatment: 1 month-2.5 years). Peritoneal dialysis was stopped at the time of diagnosis in 2 cases. In the other 4 cases, PD had been withdrawn some time prior to the SEP being diagnosed (2 weeks-5 years). Five of the patients have died; the 6th currently uses hemodialysis.
Jenkins
S B
SB
Sheffield Kidney Institute, Northern General Hospital, Herries Road, Sheffield, South Yorkshire S6 6FP, U.K.
Leng
B L
BL
Shortland
J R
JR
Brown
P W
PW
Wilkie
M E
ME
D000328:Adult; D000368:Aged; D015314:Dialysis Solutions; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D012307:Risk Factors; D012598:Sclerosis
D015314:Dialysis Solutions